Orum Therapeutics reels in $30 mln Series B
Cambridge, Massachusetts-based Orum Therapeutics, a biotech firm, has secured $30 million in Series B financing. The investors were IMM Investment, Smilegate Investment, KTB Network, Stassets Investment, InterVest and KB Investment/Solidus Investment.
17 July 2019•1 min read
